

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 9.76534076 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.27579040 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 9.27579040 |
| 4 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 8.40384756 |
| 5 | * respiratory electron transport chain (GO:0022904) | 7.91857134 |
| 6 | * electron transport chain (GO:0022900) | 7.71734842 |
| 7 | oxidative phosphorylation (GO:0006119) | 5.69574747 |
| 8 | ATP biosynthetic process (GO:0006754) | 5.48392973 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 5.27722062 |
| 10 | protein complex biogenesis (GO:0070271) | 4.93415395 |
| 11 | inner mitochondrial membrane organization (GO:0007007) | 4.86817990 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.86267576 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.86267576 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.86267576 |
| 15 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.85135930 |
| 16 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.79848580 |
| 17 | hydrogen ion transmembrane transport (GO:1902600) | 4.77157236 |
| 18 | chaperone-mediated protein transport (GO:0072321) | 4.67393114 |
| 19 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.57628912 |
| 20 | NADH metabolic process (GO:0006734) | 4.43617074 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.37368474 |
| 22 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.26427316 |
| 23 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.22115711 |
| 24 | proton transport (GO:0015992) | 4.17087862 |
| 25 | hydrogen transport (GO:0006818) | 4.10605718 |
| 26 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.09887487 |
| 27 | sarcomere organization (GO:0045214) | 4.07967562 |
| 28 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.04531246 |
| 29 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.02622223 |
| 30 | negative regulation of ligase activity (GO:0051352) | 4.02622223 |
| 31 | succinate metabolic process (GO:0006105) | 4.00560156 |
| 32 | regulation of oxidative phosphorylation (GO:0002082) | 3.99008861 |
| 33 | protein deneddylation (GO:0000338) | 3.99006774 |
| 34 | protein neddylation (GO:0045116) | 3.92376170 |
| 35 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.89710553 |
| 36 | aerobic respiration (GO:0009060) | 3.88160496 |
| 37 | establishment of integrated proviral latency (GO:0075713) | 3.88001867 |
| 38 | ubiquinone biosynthetic process (GO:0006744) | 3.76345629 |
| 39 | quinone biosynthetic process (GO:1901663) | 3.76345629 |
| 40 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.75669533 |
| 41 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.72846111 |
| 42 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.70490471 |
| 43 | ribosomal small subunit assembly (GO:0000028) | 3.67842704 |
| 44 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.67614091 |
| 45 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.66568505 |
| 46 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.66568505 |
| 47 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.65055221 |
| 48 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.65055221 |
| 49 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.65055221 |
| 50 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.62762847 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 3.61637818 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 3.61637818 |
| 53 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.60304829 |
| 54 | termination of RNA polymerase III transcription (GO:0006386) | 3.57218875 |
| 55 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.57218875 |
| 56 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.55869731 |
| 57 | mitochondrial transport (GO:0006839) | 3.55116451 |
| 58 | regulation of cellular respiration (GO:0043457) | 3.54900528 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.54569079 |
| 60 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.54569079 |
| 61 | muscle filament sliding (GO:0030049) | 3.54416111 |
| 62 | actin-myosin filament sliding (GO:0033275) | 3.54416111 |
| 63 | viral transcription (GO:0019083) | 3.53599720 |
| 64 | heart process (GO:0003015) | 3.53268371 |
| 65 | heart contraction (GO:0060047) | 3.53268371 |
| 66 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.51923015 |
| 67 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.47854500 |
| 68 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.46710787 |
| 69 | cotranslational protein targeting to membrane (GO:0006613) | 3.46434459 |
| 70 | ubiquinone metabolic process (GO:0006743) | 3.45657256 |
| 71 | translational termination (GO:0006415) | 3.45136915 |
| 72 | positive regulation of ligase activity (GO:0051351) | 3.43548248 |
| 73 | protein targeting to ER (GO:0045047) | 3.41420372 |
| 74 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.40964499 |
| 75 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.40964499 |
| 76 | regulation of mitochondrial translation (GO:0070129) | 3.40326671 |
| 77 | establishment of viral latency (GO:0019043) | 3.35959724 |
| 78 | translation (GO:0006412) | 3.33672856 |
| 79 | DNA damage response, detection of DNA damage (GO:0042769) | 3.31941442 |
| 80 | respiratory chain complex IV assembly (GO:0008535) | 3.30752323 |
| 81 | protein targeting to mitochondrion (GO:0006626) | 3.30121444 |
| 82 | protein localization to endoplasmic reticulum (GO:0070972) | 3.29669134 |
| 83 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.28584398 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.26861931 |
| 85 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.26606077 |
| 86 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.26606077 |
| 87 | rRNA modification (GO:0000154) | 3.25966492 |
| 88 | ribosomal large subunit biogenesis (GO:0042273) | 3.25675089 |
| 89 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.24004284 |
| 90 | establishment of protein localization to mitochondrion (GO:0072655) | 3.23212419 |
| 91 | protein maturation by protein folding (GO:0022417) | 3.22699704 |
| 92 | cytochrome complex assembly (GO:0017004) | 3.21771571 |
| 93 | maturation of SSU-rRNA (GO:0030490) | 3.20597294 |
| 94 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.20179405 |
| 95 | * generation of precursor metabolites and energy (GO:0006091) | 3.18292049 |
| 96 | oxaloacetate metabolic process (GO:0006107) | 3.16769003 |
| 97 | pseudouridine synthesis (GO:0001522) | 3.13985550 |
| 98 | translational elongation (GO:0006414) | 3.13849080 |
| 99 | proteasome assembly (GO:0043248) | 3.12926080 |
| 100 | negative regulation of protein localization to cell surface (GO:2000009) | 3.12425365 |
| 101 | regulation of ligase activity (GO:0051340) | 3.11449646 |
| 102 | spliceosomal snRNP assembly (GO:0000387) | 3.11333898 |
| 103 | cardiac myofibril assembly (GO:0055003) | 3.10611156 |
| 104 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.09795499 |
| 105 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.09795499 |
| 106 | regulation of cellular amine metabolic process (GO:0033238) | 3.09286917 |
| 107 | cellular ketone body metabolic process (GO:0046950) | 3.08448874 |
| 108 | cellular respiration (GO:0045333) | 3.06733693 |
| 109 | protein localization to mitochondrion (GO:0070585) | 3.06587511 |
| 110 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.05306195 |
| 111 | regulation of cell communication by electrical coupling (GO:0010649) | 3.04218684 |
| 112 | cardiac muscle contraction (GO:0060048) | 3.03677272 |
| 113 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.02650720 |
| 114 | cellular component biogenesis (GO:0044085) | 2.96539398 |
| 115 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.95448853 |
| 116 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.95190730 |
| 117 | purine nucleoside biosynthetic process (GO:0042451) | 2.95190730 |
| 118 | chromatin remodeling at centromere (GO:0031055) | 2.94895355 |
| 119 | CENP-A containing nucleosome assembly (GO:0034080) | 2.94855328 |
| 120 | translational initiation (GO:0006413) | 2.94047948 |
| 121 | sequestering of actin monomers (GO:0042989) | 2.93591340 |
| 122 | myofibril assembly (GO:0030239) | 2.92338872 |
| 123 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.87578814 |
| 124 | viral life cycle (GO:0019058) | 2.86524348 |
| 125 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.85652608 |
| 126 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.85313651 |
| 127 | branched-chain amino acid catabolic process (GO:0009083) | 2.84354600 |
| 128 | ribosomal small subunit biogenesis (GO:0042274) | 2.81459383 |
| 129 | actin-mediated cell contraction (GO:0070252) | 2.81366581 |
| 130 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.79979856 |
| 131 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.79426155 |
| 132 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.79287206 |
| 133 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.78968953 |
| 134 | regulation of actin filament-based movement (GO:1903115) | 2.78787626 |
| 135 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.78382816 |
| 136 | cellular protein complex disassembly (GO:0043624) | 2.78321558 |
| 137 | positive regulation of cell cycle arrest (GO:0071158) | 2.78125771 |
| 138 | heme biosynthetic process (GO:0006783) | 2.75496006 |
| 139 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.73551141 |
| 140 | substantia nigra development (GO:0021762) | 2.71284772 |
| 141 | cullin deneddylation (GO:0010388) | 2.70777173 |
| 142 | intracellular protein transmembrane import (GO:0044743) | 2.70572558 |
| 143 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.69903489 |
| 144 | dopamine transport (GO:0015872) | 2.67637465 |
| 145 | ketone body metabolic process (GO:1902224) | 2.67217202 |
| 146 | aldehyde catabolic process (GO:0046185) | 2.66179676 |
| 147 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.65648951 |
| 148 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.65008418 |
| 149 | GTP biosynthetic process (GO:0006183) | 2.63736280 |
| 150 | quinone metabolic process (GO:1901661) | 2.60784240 |
| 151 | positive regulation of mitochondrial fission (GO:0090141) | 2.59369849 |
| 152 | regulation of sulfur metabolic process (GO:0042762) | 2.58735479 |
| 153 | negative regulation of response to food (GO:0032096) | 2.57943954 |
| 154 | negative regulation of appetite (GO:0032099) | 2.57943954 |
| 155 | aspartate family amino acid catabolic process (GO:0009068) | 2.56963001 |
| 156 | regulation of skeletal muscle contraction (GO:0014819) | 2.56825798 |
| 157 | protein-cofactor linkage (GO:0018065) | 2.56334701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.73407115 |
| 2 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.08622666 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.94809382 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.88274237 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.31761995 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.17292526 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.12758892 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.97989705 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.89570594 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.83209701 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.73656486 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.66579853 |
| 13 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.65719600 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.63014518 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.62170882 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.58835400 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.57020975 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.42938705 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.40683127 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.34097819 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22368549 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15389215 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.14504677 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.11744289 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.08146777 |
| 26 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.07359474 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04194043 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.02786852 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96259156 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.93945893 |
| 31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.93486829 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83326000 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.71066932 |
| 34 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.69115333 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.67810131 |
| 36 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63153562 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57242250 |
| 38 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56450612 |
| 39 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55941070 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55147641 |
| 41 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.51268096 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49318584 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.49265149 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48812136 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48448999 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45391166 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43983049 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42303343 |
| 49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41816592 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39601654 |
| 51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39512243 |
| 52 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.39491557 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39251648 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39021439 |
| 55 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.38719704 |
| 56 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.38645320 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35839348 |
| 58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35322459 |
| 59 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32765643 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.31364068 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28181241 |
| 62 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27315900 |
| 63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26835772 |
| 64 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.26704549 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22392093 |
| 66 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20650837 |
| 67 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.20257450 |
| 68 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.17702488 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15856973 |
| 70 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.15473575 |
| 71 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.14687757 |
| 72 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14013932 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13915600 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13067737 |
| 75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12062363 |
| 76 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.10632975 |
| 77 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09852792 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06558260 |
| 79 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06486679 |
| 80 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.06033753 |
| 81 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05377530 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03808250 |
| 83 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01734725 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00609469 |
| 85 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.00234165 |
| 86 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99539015 |
| 87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98442204 |
| 88 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98355717 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96522739 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95883045 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95459824 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95339372 |
| 93 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94528281 |
| 94 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.94058469 |
| 95 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.94041567 |
| 96 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93817464 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93559843 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93259985 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92605090 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92538529 |
| 101 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.92228723 |
| 102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91570672 |
| 103 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90729924 |
| 104 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90710101 |
| 105 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90552736 |
| 106 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.90514482 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89118934 |
| 108 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88548305 |
| 109 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.88134481 |
| 110 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87871052 |
| 111 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.87738417 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87545612 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87520423 |
| 114 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.87312959 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87017609 |
| 116 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86754469 |
| 117 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.86699146 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86664625 |
| 119 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.86662238 |
| 120 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85801907 |
| 121 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85703683 |
| 122 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85355351 |
| 123 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.85183582 |
| 124 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.85054063 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84655338 |
| 126 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84464536 |
| 127 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.84235030 |
| 128 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84085561 |
| 129 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.83831401 |
| 130 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83140432 |
| 131 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.82687174 |
| 132 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82611613 |
| 133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82278951 |
| 134 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.82183437 |
| 135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82017543 |
| 136 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81578389 |
| 137 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.80537295 |
| 138 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80146174 |
| 139 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.79704032 |
| 140 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79189928 |
| 141 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.78674294 |
| 142 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77987802 |
| 143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77885463 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77488747 |
| 145 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76660196 |
| 146 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.76024157 |
| 147 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.75975886 |
| 148 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.75975886 |
| 149 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.75559273 |
| 150 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.74398062 |
| 151 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.73027031 |
| 152 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.69197082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.92689239 |
| 2 | MP0003646_muscle_fatigue | 4.32373160 |
| 3 | MP0000751_myopathy | 3.72788938 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.44263618 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.29007659 |
| 6 | MP0000749_muscle_degeneration | 3.23504912 |
| 7 | MP0006036_abnormal_mitochondrial_physio | 3.13678470 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.10565736 |
| 9 | MP0005330_cardiomyopathy | 2.78387921 |
| 10 | MP0008058_abnormal_DNA_repair | 2.75302387 |
| 11 | MP0001529_abnormal_vocalization | 2.66370939 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.47667839 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.32235255 |
| 14 | MP0003137_abnormal_impulse_conducting | 2.20552656 |
| 15 | MP0003880_abnormal_central_pattern | 2.18800273 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.17634687 |
| 17 | MP0006035_abnormal_mitochondrial_morpho | 2.14765318 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.11756318 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.03844326 |
| 20 | MP0005620_abnormal_muscle_contractility | 1.96672513 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.95637003 |
| 22 | MP0004484_altered_response_of | 1.92318635 |
| 23 | MP0001905_abnormal_dopamine_level | 1.90951719 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.89204105 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 1.87792817 |
| 26 | MP0008932_abnormal_embryonic_tissue | 1.86577369 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.85713687 |
| 28 | MP0003718_maternal_effect | 1.83234015 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.81144279 |
| 30 | MP0000750_abnormal_muscle_regeneration | 1.78983467 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.78408350 |
| 32 | MP0002106_abnormal_muscle_physiology | 1.72847429 |
| 33 | MP0003786_premature_aging | 1.71768737 |
| 34 | MP0008789_abnormal_olfactory_epithelium | 1.71227364 |
| 35 | MP0001544_abnormal_cardiovascular_syste | 1.68929154 |
| 36 | MP0005385_cardiovascular_system_phenoty | 1.68929154 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.66039305 |
| 38 | MP0004085_abnormal_heartbeat | 1.63603138 |
| 39 | MP0002822_catalepsy | 1.62705198 |
| 40 | MP0002938_white_spotting | 1.60557746 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.56444307 |
| 42 | MP0004142_abnormal_muscle_tone | 1.55810875 |
| 43 | MP0006292_abnormal_olfactory_placode | 1.55680558 |
| 44 | MP0006138_congestive_heart_failure | 1.55679411 |
| 45 | MP0003136_yellow_coat_color | 1.54365354 |
| 46 | MP0002102_abnormal_ear_morphology | 1.52533910 |
| 47 | MP0002736_abnormal_nociception_after | 1.51843729 |
| 48 | MP0003077_abnormal_cell_cycle | 1.49281552 |
| 49 | MP0000747_muscle_weakness | 1.47434256 |
| 50 | MP0005369_muscle_phenotype | 1.41377858 |
| 51 | MP0003195_calcinosis | 1.39611023 |
| 52 | MP0009046_muscle_twitch | 1.39427058 |
| 53 | MP0002269_muscular_atrophy | 1.39142181 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.38455040 |
| 55 | MP0003186_abnormal_redox_activity | 1.38273556 |
| 56 | MP0005670_abnormal_white_adipose | 1.37572850 |
| 57 | MP0000759_abnormal_skeletal_muscle | 1.35946800 |
| 58 | MP0009745_abnormal_behavioral_response | 1.35446897 |
| 59 | MP0002064_seizures | 1.35438122 |
| 60 | MP0003011_delayed_dark_adaptation | 1.35039052 |
| 61 | MP0002272_abnormal_nervous_system | 1.34777517 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.33951253 |
| 63 | MP0001968_abnormal_touch/_nociception | 1.28564556 |
| 64 | MP0004147_increased_porphyrin_level | 1.28167342 |
| 65 | MP0005332_abnormal_amino_acid | 1.26001013 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25989552 |
| 67 | MP0005451_abnormal_body_composition | 1.25942060 |
| 68 | MP0004130_abnormal_muscle_cell | 1.24907893 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.24082960 |
| 70 | MP0005266_abnormal_metabolism | 1.23938722 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.20006672 |
| 72 | MP0000358_abnormal_cell_content/ | 1.19606580 |
| 73 | MP0001440_abnormal_grooming_behavior | 1.19283606 |
| 74 | MP0004924_abnormal_behavior | 1.15059397 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.15059397 |
| 76 | MP0005083_abnormal_biliary_tract | 1.15043624 |
| 77 | MP0005499_abnormal_olfactory_system | 1.14586419 |
| 78 | MP0005394_taste/olfaction_phenotype | 1.14586419 |
| 79 | MP0000230_abnormal_systemic_arterial | 1.13382131 |
| 80 | MP0003123_paternal_imprinting | 1.13138470 |
| 81 | MP0005085_abnormal_gallbladder_physiolo | 1.12842485 |
| 82 | MP0005535_abnormal_body_temperature | 1.12601151 |
| 83 | MP0004043_abnormal_pH_regulation | 1.12252843 |
| 84 | MP0008007_abnormal_cellular_replicative | 1.10175801 |
| 85 | MP0005360_urolithiasis | 1.08714721 |
| 86 | MP0008995_early_reproductive_senescence | 1.06450713 |
| 87 | MP0004510_myositis | 1.04462081 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 1.03350373 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 1.03311915 |
| 90 | MP0003635_abnormal_synaptic_transmissio | 1.02629722 |
| 91 | MP0001984_abnormal_olfaction | 1.01390300 |
| 92 | MP0001970_abnormal_pain_threshold | 1.01313847 |
| 93 | MP0002572_abnormal_emotion/affect_behav | 1.00317288 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.99755264 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99653251 |
| 96 | MP0002160_abnormal_reproductive_system | 0.98037214 |
| 97 | MP0005423_abnormal_somatic_nervous | 0.97255602 |
| 98 | MP0005165_increased_susceptibility_to | 0.97225080 |
| 99 | MP0002127_abnormal_cardiovascular_syste | 0.96628253 |
| 100 | MP0004270_analgesia | 0.95697051 |
| 101 | MP0009697_abnormal_copulation | 0.95427294 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.95390785 |
| 103 | MP0002090_abnormal_vision | 0.95019718 |
| 104 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94240290 |
| 105 | MP0000343_altered_response_to | 0.92713223 |
| 106 | MP0003315_abnormal_perineum_morphology | 0.90977239 |
| 107 | MP0002067_abnormal_sensory_capabilities | 0.90893504 |
| 108 | MP0005253_abnormal_eye_physiology | 0.90260431 |
| 109 | MP0003329_amyloid_beta_deposits | 0.89573756 |
| 110 | MP0005408_hypopigmentation | 0.87970541 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.87885421 |
| 112 | MP0002733_abnormal_thermal_nociception | 0.87135933 |
| 113 | MP0002210_abnormal_sex_determination | 0.86298982 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.84194801 |
| 115 | MP0005636_abnormal_mineral_homeostasis | 0.83703257 |
| 116 | MP0002063_abnormal_learning/memory/cond | 0.82438460 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.81786061 |
| 118 | MP0003941_abnormal_skin_development | 0.81704390 |
| 119 | MP0003122_maternal_imprinting | 0.80768132 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.80139495 |
| 121 | MP0008877_abnormal_DNA_methylation | 0.79337498 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.79322346 |
| 123 | MP0003828_pulmonary_edema | 0.78306936 |
| 124 | MP0001486_abnormal_startle_reflex | 0.76911324 |
| 125 | MP0002653_abnormal_ependyma_morphology | 0.76798511 |
| 126 | MP0001293_anophthalmia | 0.76271923 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.76107541 |
| 128 | MP0004233_abnormal_muscle_weight | 0.75544193 |
| 129 | MP0003121_genomic_imprinting | 0.75113215 |
| 130 | MP0008872_abnormal_physiological_respon | 0.74672985 |
| 131 | MP0005551_abnormal_eye_electrophysiolog | 0.74594175 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.74565252 |
| 133 | MP0000049_abnormal_middle_ear | 0.74503114 |
| 134 | MP0000920_abnormal_myelination | 0.73277183 |
| 135 | MP0001764_abnormal_homeostasis | 0.71644613 |
| 136 | MP0001929_abnormal_gametogenesis | 0.70289474 |
| 137 | MP0004859_abnormal_synaptic_plasticity | 0.70049474 |
| 138 | MP0000013_abnormal_adipose_tissue | 0.69101116 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.69028100 |
| 140 | MP0000372_irregular_coat_pigmentation | 0.68545659 |
| 141 | MP0002638_abnormal_pupillary_reflex | 0.68498419 |
| 142 | MP0001188_hyperpigmentation | 0.65569258 |
| 143 | MP0002095_abnormal_skin_pigmentation | 0.65051057 |
| 144 | MP0002066_abnormal_motor_capabilities/c | 0.64707609 |
| 145 | MP0003879_abnormal_hair_cell | 0.62362959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.01767243 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.60172800 |
| 3 | Mitochondrial inheritance (HP:0001427) | 6.11018055 |
| 4 | Acute encephalopathy (HP:0006846) | 6.01597341 |
| 5 | Progressive macrocephaly (HP:0004481) | 5.83272434 |
| 6 | Hepatocellular necrosis (HP:0001404) | 5.77558775 |
| 7 | Hepatic necrosis (HP:0002605) | 5.51857134 |
| 8 | Increased CSF lactate (HP:0002490) | 5.37305677 |
| 9 | Cerebral edema (HP:0002181) | 4.83753621 |
| 10 | Abnormality of glycolysis (HP:0004366) | 4.23984488 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.23984488 |
| 12 | Sudden death (HP:0001699) | 4.16966228 |
| 13 | Lactic acidosis (HP:0003128) | 4.16217634 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 4.12112540 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 4.05958402 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 4.05763690 |
| 17 | Exercise intolerance (HP:0003546) | 4.01922197 |
| 18 | Respiratory failure (HP:0002878) | 4.00128370 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.87255322 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.87133215 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.77931878 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.77931878 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 3.70002220 |
| 24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.66066932 |
| 25 | Increased serum lactate (HP:0002151) | 3.55042242 |
| 26 | Renal Fanconi syndrome (HP:0001994) | 3.53219304 |
| 27 | Optic disc pallor (HP:0000543) | 3.46582136 |
| 28 | Leukodystrophy (HP:0002415) | 3.42042881 |
| 29 | Pheochromocytoma (HP:0002666) | 3.40004491 |
| 30 | Palpitations (HP:0001962) | 3.39162680 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.38013110 |
| 32 | Neuroendocrine neoplasm (HP:0100634) | 3.33977762 |
| 33 | Exercise-induced myalgia (HP:0003738) | 3.17623558 |
| 34 | Ventricular tachycardia (HP:0004756) | 3.08974875 |
| 35 | Myoglobinuria (HP:0002913) | 3.08915040 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 3.08539762 |
| 37 | Exercise-induced muscle cramps (HP:0003710) | 3.07903989 |
| 38 | Abnormal number of erythroid precursors (HP:0012131) | 2.93914630 |
| 39 | Lethargy (HP:0001254) | 2.78957998 |
| 40 | Muscle fiber splitting (HP:0003555) | 2.78398579 |
| 41 | Atrial fibrillation (HP:0005110) | 2.74912641 |
| 42 | Type I transferrin isoform profile (HP:0003642) | 2.74751507 |
| 43 | Rhabdomyolysis (HP:0003201) | 2.74706768 |
| 44 | Abnormality of the calf musculature (HP:0001430) | 2.73766762 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71525319 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.71525319 |
| 47 | CNS demyelination (HP:0007305) | 2.66790042 |
| 48 | Myotonia (HP:0002486) | 2.63981321 |
| 49 | Lipoatrophy (HP:0100578) | 2.63792081 |
| 50 | Supraventricular tachycardia (HP:0004755) | 2.60542900 |
| 51 | Primary atrial arrhythmia (HP:0001692) | 2.57614320 |
| 52 | Exertional dyspnea (HP:0002875) | 2.56025973 |
| 53 | Macrocytic anemia (HP:0001972) | 2.55118483 |
| 54 | Ragged-red muscle fibers (HP:0003200) | 2.54167150 |
| 55 | Supraventricular arrhythmia (HP:0005115) | 2.52835353 |
| 56 | Respiratory difficulties (HP:0002880) | 2.52156793 |
| 57 | Conjunctival hamartoma (HP:0100780) | 2.51404587 |
| 58 | Dilated cardiomyopathy (HP:0001644) | 2.45212601 |
| 59 | Nemaline bodies (HP:0003798) | 2.44027563 |
| 60 | X-linked dominant inheritance (HP:0001423) | 2.42010784 |
| 61 | Glycosuria (HP:0003076) | 2.40607205 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.40607205 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.39800597 |
| 64 | Syncope (HP:0001279) | 2.36265793 |
| 65 | Emotional lability (HP:0000712) | 2.35590084 |
| 66 | Muscle fiber inclusion bodies (HP:0100299) | 2.32860797 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32501212 |
| 68 | Abnormality of alanine metabolism (HP:0010916) | 2.32501212 |
| 69 | Hyperalaninemia (HP:0003348) | 2.32501212 |
| 70 | Reticulocytopenia (HP:0001896) | 2.32112923 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.31816455 |
| 72 | Vomiting (HP:0002013) | 2.31355499 |
| 73 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.30248526 |
| 74 | Cerebral hemorrhage (HP:0001342) | 2.25785583 |
| 75 | EMG: myopathic abnormalities (HP:0003458) | 2.25572314 |
| 76 | Abnormality of renal resorption (HP:0011038) | 2.23407798 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.22449699 |
| 78 | Abnormality of the anterior horn cell (HP:0006802) | 2.17915381 |
| 79 | Degeneration of anterior horn cells (HP:0002398) | 2.17915381 |
| 80 | Prolonged QT interval (HP:0001657) | 2.17781444 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.17553166 |
| 82 | Hyperglycinemia (HP:0002154) | 2.16964667 |
| 83 | Ketoacidosis (HP:0001993) | 2.15761638 |
| 84 | Muscle stiffness (HP:0003552) | 2.14721490 |
| 85 | Cerebral palsy (HP:0100021) | 2.13923278 |
| 86 | Aplastic anemia (HP:0001915) | 2.13733978 |
| 87 | Abnormal protein glycosylation (HP:0012346) | 2.08164331 |
| 88 | Abnormal glycosylation (HP:0012345) | 2.08164331 |
| 89 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08164331 |
| 90 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08164331 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.07401102 |
| 92 | Esophageal neoplasm (HP:0100751) | 2.05348333 |
| 93 | Neoplasm of head and neck (HP:0012288) | 2.05348333 |
| 94 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04417859 |
| 95 | Progressive external ophthalmoplegia (HP:0000590) | 2.02642194 |
| 96 | Myokymia (HP:0002411) | 2.01397345 |
| 97 | Abnormality of placental membranes (HP:0011409) | 2.00517794 |
| 98 | Amniotic constriction ring (HP:0009775) | 2.00517794 |
| 99 | Gliosis (HP:0002171) | 1.97243540 |
| 100 | Left ventricular hypertrophy (HP:0001712) | 1.97156500 |
| 101 | Testicular atrophy (HP:0000029) | 1.97105796 |
| 102 | Hyperphosphaturia (HP:0003109) | 1.95396761 |
| 103 | Hyporeflexia of lower limbs (HP:0002600) | 1.94409372 |
| 104 | Asymmetric septal hypertrophy (HP:0001670) | 1.91116186 |
| 105 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89745529 |
| 106 | Ketosis (HP:0001946) | 1.89439900 |
| 107 | Paralysis (HP:0003470) | 1.89127804 |
| 108 | Metabolic acidosis (HP:0001942) | 1.86767332 |
| 109 | Cholecystitis (HP:0001082) | 1.86696519 |
| 110 | Abnormal gallbladder physiology (HP:0012438) | 1.86696519 |
| 111 | Abnormality of the vocal cords (HP:0008777) | 1.86664291 |
| 112 | Oral leukoplakia (HP:0002745) | 1.85769433 |
| 113 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84868479 |
| 114 | Ventricular arrhythmia (HP:0004308) | 1.84575316 |
| 115 | Sparse eyelashes (HP:0000653) | 1.83318329 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 1.82568996 |
| 117 | Gout (HP:0001997) | 1.82184006 |
| 118 | Progressive muscle weakness (HP:0003323) | 1.82136451 |
| 119 | Methylmalonic acidemia (HP:0002912) | 1.81818517 |
| 120 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.79673306 |
| 121 | Athetosis (HP:0002305) | 1.78114373 |
| 122 | Poor suck (HP:0002033) | 1.77122887 |
| 123 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76409143 |
| 124 | Pancytopenia (HP:0001876) | 1.76125889 |
| 125 | Hyperammonemia (HP:0001987) | 1.74119650 |
| 126 | Hypoplastic left heart (HP:0004383) | 1.73547638 |
| 127 | Rimmed vacuoles (HP:0003805) | 1.73193978 |
| 128 | Ventricular fibrillation (HP:0001663) | 1.70163611 |
| 129 | Abnormality of methionine metabolism (HP:0010901) | 1.70140331 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.69998624 |
| 131 | Neoplasm of the adrenal gland (HP:0100631) | 1.69778580 |
| 132 | Abnormal EKG (HP:0003115) | 1.68742105 |
| 133 | Microvesicular hepatic steatosis (HP:0001414) | 1.68569218 |
| 134 | Hyperglycinuria (HP:0003108) | 1.68479001 |
| 135 | Hypoglycemic coma (HP:0001325) | 1.67524974 |
| 136 | Nausea (HP:0002018) | 1.66956531 |
| 137 | Blindness (HP:0000618) | 1.66944777 |
| 138 | Rough bone trabeculation (HP:0100670) | 1.66536308 |
| 139 | CNS hypomyelination (HP:0003429) | 1.61769305 |
| 140 | Multiple enchondromatosis (HP:0005701) | 1.60859099 |
| 141 | Abnormality of the labia minora (HP:0012880) | 1.60610968 |
| 142 | Unsteady gait (HP:0002317) | 1.60030163 |
| 143 | Delayed CNS myelination (HP:0002188) | 1.57860149 |
| 144 | Pallor (HP:0000980) | 1.56182750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.43112935 |
| 2 | MYLK | 3.89897356 |
| 3 | MAP3K12 | 3.31088805 |
| 4 | BCKDK | 3.15919058 |
| 5 | NME1 | 3.01856739 |
| 6 | NME2 | 2.97914534 |
| 7 | OBSCN | 2.96531985 |
| 8 | MUSK | 2.62760795 |
| 9 | ARAF | 2.36889176 |
| 10 | PDK3 | 2.29823377 |
| 11 | PDK4 | 2.29823377 |
| 12 | STK16 | 2.18628434 |
| 13 | GRK7 | 2.11220547 |
| 14 | PHKG2 | 2.10710085 |
| 15 | PHKG1 | 2.10710085 |
| 16 | LIMK1 | 2.06687620 |
| 17 | STK39 | 2.03611214 |
| 18 | CDC7 | 1.99242342 |
| 19 | MAP2K7 | 1.98623007 |
| 20 | TTN | 1.96923195 |
| 21 | WNK4 | 1.94005346 |
| 22 | TIE1 | 1.80536928 |
| 23 | CASK | 1.75924810 |
| 24 | CDK19 | 1.59301586 |
| 25 | KDR | 1.55071557 |
| 26 | BUB1 | 1.54894280 |
| 27 | GRK5 | 1.53363399 |
| 28 | OXSR1 | 1.52495356 |
| 29 | PINK1 | 1.51992560 |
| 30 | LMTK2 | 1.42748717 |
| 31 | TTK | 1.41667511 |
| 32 | TSSK6 | 1.38605881 |
| 33 | PLK3 | 1.34202719 |
| 34 | PDK2 | 1.31746007 |
| 35 | EIF2AK1 | 1.28006916 |
| 36 | CCNB1 | 1.26678695 |
| 37 | CAMK2D | 1.25794471 |
| 38 | MAP2K4 | 1.25527259 |
| 39 | MAP3K4 | 1.23900807 |
| 40 | CSNK1G2 | 1.22854111 |
| 41 | PIK3CA | 1.21392361 |
| 42 | WEE1 | 1.21124015 |
| 43 | TRIM28 | 1.20885258 |
| 44 | ZAK | 1.20624373 |
| 45 | DAPK3 | 1.18817793 |
| 46 | PLK4 | 1.16420566 |
| 47 | CSNK1G1 | 1.14380219 |
| 48 | ILK | 1.14308788 |
| 49 | PLK1 | 1.09408861 |
| 50 | CSNK1A1L | 1.07367632 |
| 51 | TNIK | 1.06346354 |
| 52 | CAMK2A | 1.06004433 |
| 53 | MAPKAPK5 | 1.03793359 |
| 54 | PIM2 | 1.03424132 |
| 55 | MAP3K11 | 1.00373397 |
| 56 | CAMK2G | 0.96449911 |
| 57 | ABL2 | 0.96402770 |
| 58 | BRSK1 | 0.95440838 |
| 59 | MAP4K2 | 0.92845089 |
| 60 | ADRBK2 | 0.91168713 |
| 61 | BMPR1B | 0.85445276 |
| 62 | PAK4 | 0.85281808 |
| 63 | NEK1 | 0.84294985 |
| 64 | MAPK12 | 0.83879144 |
| 65 | CAMK2B | 0.82871586 |
| 66 | EIF2AK3 | 0.82744917 |
| 67 | PTK2B | 0.82229123 |
| 68 | TLK1 | 0.80689009 |
| 69 | AURKB | 0.79385553 |
| 70 | ROCK2 | 0.79117725 |
| 71 | NTRK3 | 0.78691120 |
| 72 | BCR | 0.78443216 |
| 73 | PBK | 0.77061977 |
| 74 | PKN1 | 0.76031031 |
| 75 | STK24 | 0.73377697 |
| 76 | BRAF | 0.73364831 |
| 77 | MINK1 | 0.72696004 |
| 78 | PAK3 | 0.71938951 |
| 79 | CAMKK2 | 0.71762427 |
| 80 | MST4 | 0.70811695 |
| 81 | MARK1 | 0.70679221 |
| 82 | SCYL2 | 0.70575050 |
| 83 | DYRK3 | 0.69814851 |
| 84 | STK4 | 0.69605207 |
| 85 | PLK2 | 0.69131735 |
| 86 | VRK1 | 0.69098489 |
| 87 | UHMK1 | 0.68027467 |
| 88 | NUAK1 | 0.67165897 |
| 89 | PRKCE | 0.67057732 |
| 90 | ADRBK1 | 0.66729680 |
| 91 | CSNK2A2 | 0.66526810 |
| 92 | TESK1 | 0.64173231 |
| 93 | PRKACA | 0.63737329 |
| 94 | CSNK2A1 | 0.62406504 |
| 95 | PRKCG | 0.59736728 |
| 96 | ROCK1 | 0.56347695 |
| 97 | MAPK13 | 0.56042565 |
| 98 | CAMK1 | 0.55826398 |
| 99 | ATR | 0.55689464 |
| 100 | BMPR2 | 0.54875302 |
| 101 | PAK1 | 0.53260916 |
| 102 | CHEK2 | 0.52359845 |
| 103 | INSRR | 0.51085189 |
| 104 | RPS6KA5 | 0.50657657 |
| 105 | CDK11A | 0.50508359 |
| 106 | CDK8 | 0.50067914 |
| 107 | CDK15 | 0.49324540 |
| 108 | GRK1 | 0.48651434 |
| 109 | DAPK1 | 0.44797704 |
| 110 | ERBB3 | 0.42730164 |
| 111 | MAPKAPK3 | 0.41962007 |
| 112 | MAP2K6 | 0.41597862 |
| 113 | PRKCI | 0.41374772 |
| 114 | AKT2 | 0.41132125 |
| 115 | PNCK | 0.40966761 |
| 116 | CSNK1G3 | 0.40683766 |
| 117 | PRKACB | 0.40428036 |
| 118 | DYRK2 | 0.39987063 |
| 119 | CSNK1A1 | 0.39759978 |
| 120 | CSNK1E | 0.39341416 |
| 121 | TESK2 | 0.38616345 |
| 122 | CDK14 | 0.38005575 |
| 123 | SRPK1 | 0.36561323 |
| 124 | MAPK4 | 0.36112889 |
| 125 | CDK5 | 0.36018318 |
| 126 | PRKD1 | 0.35518904 |
| 127 | LRRK2 | 0.35186383 |
| 128 | MAP3K5 | 0.33654086 |
| 129 | EPHA4 | 0.33306505 |
| 130 | AURKA | 0.32836431 |
| 131 | SGK223 | 0.32545132 |
| 132 | SGK494 | 0.32545132 |
| 133 | WNK3 | 0.31966692 |
| 134 | PRKCD | 0.31848218 |
| 135 | CDK18 | 0.29816619 |
| 136 | PRKACG | 0.29554032 |
| 137 | MAP2K1 | 0.28140613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.07771029 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.37131994 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.98488651 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.82885407 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.57971162 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.37844886 |
| 7 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.34052621 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.76769270 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.51730841 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.46692033 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34599673 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.31108045 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.25034581 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23100589 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.12100204 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07811253 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.83644952 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82698929 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81601194 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.77342618 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.74613663 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74323399 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68247662 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.66259017 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62347441 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53066507 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.50809528 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.43138452 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.38635832 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.35219012 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28996249 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25783436 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24143518 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19115449 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.15012586 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11768119 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11517787 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.07790459 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.07656147 |
| 40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06484381 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99678098 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98473427 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 0.97933008 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97257090 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94470065 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90549888 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89774191 |
| 48 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.87747050 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86898422 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86780489 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85324358 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80891974 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79106522 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76073340 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71853521 |
| 56 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.71619840 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71572067 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69373703 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68369239 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66035812 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63801359 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.62130675 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55904668 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55615403 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54962007 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54430748 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53859219 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50716102 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.49761763 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49708256 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48211982 |
| 72 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.47743291 |
| 73 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45945415 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43809594 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43480381 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42061148 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40794565 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40173170 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39353293 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39143626 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38522872 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.38114882 |
| 83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37872396 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.37724414 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.37596162 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.37397834 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37370601 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36444524 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35772677 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35770174 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33313447 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31696802 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30798526 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28913731 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28693739 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28188538 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.26682125 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24108113 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.23054630 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.22927349 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22205786 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21981203 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.21472125 |
| 104 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.20275831 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.20085899 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.18593380 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.18028615 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16932272 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16923060 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16775263 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.16436016 |
| 112 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.15930819 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.14970896 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14755256 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14295261 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.14204831 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13610598 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13541482 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13482795 |
| 120 | Renin secretion_Homo sapiens_hsa04924 | 0.12940768 |
| 121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.12777282 |
| 122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.12711128 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11387496 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.10425834 |
| 125 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.09968186 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09914275 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09115628 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08629186 |

